Moreover, recently we applied an innovative CRISPR/Cas9 gene editing technique to create bi-allelic mutations in induced pluripotent stem cells (iPSCs) in order to express the AMD-linked variant B form of cystatin C under its endogenous promoter [21]. Here, CST3 is linked to age-related macular degeneration.